Invezz

Azenta (AZTA)

NasdaqMarket Closed

Azenta, Inc. is a life sciences technology company that provides sample management, automated storage and genomic services to pharmaceutical, biotechnology, academic and healthcare research customers. The company supports the handling of biological and chemical materials across the research and development cycle, from early discovery work through later-stage commercial and clinical applications.

Azenta’s core expertise is in preserving, organising and analysing high-value samples. Its Sample Management Solutions business supplies automated storage systems, cryogenic and ultra-cold storage technologies, sample tubes, consumables, instruments, thawing devices and related products. These systems help laboratories and research organisations protect the integrity of samples while improving retrieval, tracking and workflow efficiency. This segment represents the company’s largest source of revenue and reflects Azenta’s background in precision automation and cold-chain technologies.

The company also operates a Multiomics business, which provides genomic analysis and related services. These offerings are used by customers seeking insights from DNA, RNA and other biological data, supporting applications such as drug discovery, translational research and broader life sciences development. Azenta’s informatics and repository services complement these capabilities by helping customers store, track and manage complex sample and data collections.

Azenta serves an international customer base, with operations and revenue exposure across the United States, China, the United Kingdom, Europe and other regions. The United States is its largest market. What distinguishes Azenta is its combination of physical sample infrastructure, laboratory automation, consumables and analytical services, positioning the company as an enabling partner for organisations that depend on reliable biological sample preservation and data generation.

32.88USD
33.27 USD
−4.52(-12.09%)
Pre-market

Last updated

Market Cap
$1,638,433,898
P/E
P/FCF
165.82
P/S
2.67
Enterprise Value
$1,448,779,898
Sector
Industrials
Industry
Special Industry Machinery, Not Elsewhere Classified
Address
200 SUMMIT DRIVE, BURLINGTON, MA, 01803
yahoo.com

Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks

17 Aug 2026, 21:34 PM
globenewswire.com

Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)

21 May 2026, 23:00 PM
globenewswire.com

Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. (NASDAQ:AZTA) on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm

20 May 2026, 08:23 AM
globenewswire.com

AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

19 May 2026, 09:00 AM
globenewswire.com

AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm

19 May 2026, 04:43 AM
globenewswire.com

AZTA SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Azenta, Inc. for Possible Securities Law Violations

14 May 2026, 23:00 PM
globenewswire.com

AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

14 May 2026, 09:00 AM
globenewswire.com

AZENTA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm

13 May 2026, 07:53 AM
globenewswire.com

Bio-Preservation Market to Reach US$ 44.45 Billion by 2035 | Cold Chain Expansion and Cell & Gene Therapy Commercialization Drive Growth Says Astute Analytica

12 Feb 2026, 05:40 AM
globenewswire.com

Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™

09 Oct 2025, 02:00 AM
Market Cap
$1,638,433,898
Enterprise Value
$1,448,779,898
P/E
P/B
1.08
P/S
2.67
EV / EBITDA
53.21
EV / Sales
2.36
EPS
-2.81
Dividend Yield
0%
P/FCF
165.82
P/CF
43.15
Free Cash Flow
$9,881,000
ROE
-8.14%
ROA
-6.55%
Debt / Equity
0
Current Ratio
2.66
Quick Ratio
2.35
Cash
0.74
Avg Volume
$657,649
Fundamentals Snapshot Price
37.4

Income Statement

Line Item2026 Q32026 Q22026 Q12025 Q42025 Q3
Revenue161.18M144.8M148.64M158.95M143.86M
Cost of revenue88.82M82.76M84.94M90.99M77.45M
Gross profit72.36M62.04M63.71M67.96M66.4M
Operating income-4.18M-165.79M-7.24M1.37M-1.85M
EBITDA9.92M-1.28M7.55M11.04M13.63M
Net income2.46M-160.8M-15.43M50.84M-47.99M
Income taxes2.38M-323K3.13M-45.61M2.64M
Interest expense3.83M0004.97M
Other operating expenses513K150.51M1.14M406K754K
Total operating expenses76.53M227.83M70.94M66.59M68.25M
Basic EPS0.05-3.49-0.341.11-1.05
Diluted EPS0.05-3.49-0.341.09-1.05

Balance Sheet

Line Item2026 Q32026 Q22026 Q12025 Q42025 Q3
Total assets1.88B1.9B2.07B2.06B2.02B
Total liabilities366.08M349.21M359.6M332.6M345.5M
Total equity1.51B1.55B1.71B1.73B1.67B
Cash & equivalents189.65M234.03M336.63M279.78M270.04M
Current assets681.35M726.99M779.9M708.34M678.48M
Current liabilities256.23M235.45M243.65M223.7M230.81M
Accounts payable39.38M33.14M38.77M37.72M37.98M
Receivables149.52M138.16M150.16M151.91M124.54M
Inventories79.08M78.51M82.46M74.96M80.51M
Goodwill547.46M553.07M702.56M702.4M703.61M
Long-term debt00000

Cash Flow

Line Item2026 Q32026 Q22026 Q12025 Q42025 Q3
Operating cash flow1.45M13.51M20.85M2.17M25.81M
Investing cash flow4.72M-114.75M36.77M826K-29.7M
Financing cash flow-50.32M980K-2.63M817K-128K
Change in cash-44.62M-102.7M55.3M2.87M4.95M
Net income2.46M-160.8M-15.43M50.84M-47.99M
KindFilingDateLink
edgar index8-K — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
edgar index8-K — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
form 4Form 4 — Pirogova OlgaView Filing
edgar index10-Q — Azenta, Inc.View Filing
edgar index8-K — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
form 4Form 4 — Starr EphraimView Filing
edgar index8-K — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
edgar indexSD — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
form 4Form 4 — Cornog William LView Filing
form 4Form 4 — Starr EphraimView Filing
edgar index4 — Azenta, Inc.View Filing
edgar indexS-8 — Azenta, Inc.View Filing
edgar index10-Q — Azenta, Inc.View Filing
edgar index8-K — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
edgar index4 — Azenta, Inc.View Filing
edgar indexSCHEDULE 13G — Azenta, Inc.View Filing
form 4Form 4 — MARTIN WILLIAM E. IIIView Filing
edgar index3 — Azenta, Inc.View Filing
edgar index8-K — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
edgar index8-K — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
edgar indexSCHEDULE 13G/A — Azenta, Inc.View Filing
edgar index8-K — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4/A — Azenta, Inc.View Filing
form 4Form 4 — Nova Tina SusanView Filing
edgar index10-Q — Azenta, Inc.View Filing
form 4Form 4 — Koffey QuentinView Filing
form 4Form 4 — Koffey QuentinView Filing
form 4Form 4 — Davis Robyn CView Filing
form 4Form 4 — McLaughlin EricaView Filing
form 4Form 4 — Casal FrankView Filing
form 4Form 4 — Doshi DipalView Filing
form 4Form 4 — Madaus Martin DView Filing
form 4Form 4 — Cornog William LView Filing
form 4Form 4 — Cornog William LView Filing
edgar index8-K — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
edgar index8-K — Azenta, Inc.View Filing
eight k text8-K — 8-KView Filing
edgar index8-K — Azenta, Inc.View Filing
edgar indexSCHEDULE 13G/A — Azenta, Inc.View Filing
edgar index8-K — Azenta, Inc.View Filing
edgar indexARS — Azenta, Inc.View Filing
edgar indexDEFR14A — Azenta, Inc.View Filing
edgar indexDEF 14A — Azenta, Inc.View Filing
edgar indexDEFA14A — Azenta, Inc.View Filing
edgar index8-K — Azenta, Inc.View Filing
edgar index10-K — Azenta, Inc.View Filing
ten k section10-K — businessView Filing
ten k section10-K — risk_factorsView Filing
edgar index4/A — Azenta, Inc.View Filing
edgar indexNT 10-K — Azenta, Inc.View Filing
edgar index4/A — Azenta, Inc.View Filing
edgar index4/A — Azenta, Inc.View Filing
edgar index4/A — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing
edgar index4 — Azenta, Inc.View Filing